| Financial Year |
March 31 2023 |
| Monetary Funds |
2,602,235,451.20 |
| Held-for-trading Financial Assets |
5,854,532.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
415,730,029.31 |
| Advances to Suppliers |
59,722,605.28 |
| Other Receivables |
17,534,911.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
526,744,476.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,209,693.57 |
| Total Current Assets |
3,660,348,521.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,858,785.76 |
| Investment Properties |
-- |
| Fixed Assetes |
748,136,639.09 |
| Under-construction Projects |
514,187,191.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
768,037,484.12 |
| R&D expenses |
-- |
| Goodwill |
411,532,862.79 |
| Long-Term Deferred and Prepaid Expenses |
7,567,907.18 |
| Deferred Income Tax Assets |
55,576,429.31 |
| Other Non-Current Assets |
104,401,580.35 |
| Sub-Total of Non-Current Assets |
3,323,687,623.67 |
| Total Assets |
6,984,036,145.39 |
| Short-Term Loans |
90,652.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
202,117.30 |
| Accounts Payable |
85,676,097.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,775,473.87 |
| Taxes Payable |
55,283,453.94 |
| Interest Payable |
-- |
| Dividend Payable |
1,200,000.00 |
| Other payables |
240,086,780.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,533,815.71 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
523,418,974.28 |
| Long-term Loans |
137,254,152.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,139,966.46 |
| Deferred Income Tax Liabilities |
160,088,554.52 |
| Other Non-Current Liabilities |
220,559,760.00 |
| Sub-Total of Non-Current Liabilities |
563,623,031.64 |
| Total Liabilities |
1,087,042,005.92 |
| Paid-In Capital(Or Share Stock) |
171,271,000.00 |
| Capital Surplus |
2,852,508,168.27 |
| Surplus Reserve |
88,922,650.00 |
| LESS:Treasury Stock |
4,273,839.74 |
| Undistributed Profits |
2,460,397,569.21 |
| Minority Stockholder's Interest |
382,502,081.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,514,492,058.38 |
| Owner's Equity（Stockholder's Equity） |
5,896,994,139.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,984,036,145.39 |
